From the Food and Drug Administration.
Nightingale
S L
SL
D000163:Acquired Immunodeficiency Syndrome; D001943:Breast Neoplasms / Q000188:drug therapy; D003275:Contraceptive Devices, Male; D015507:Drugs, Investigational / Q000627:therapeutic use; D005260:Female; D005515:Food Labeling / Q000331:legislation & jurisprudence*; D005776:Gaucher Disease / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D012749:Sexually Transmitted Diseases; D013629:Tamoxifen / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D013629:Tamoxifen